Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Susceptible Infections |
Dose: Intravenous Administration – 5-7.5 mg/kg/dose Frequency: divided every 8-12 hours Note: not to exceed 15 mg/kg/day divided every 6-12 hours; administer slowly |
|
Indication: Susceptible Infections |
Dose: Intramuscular Administration – 5-7.5 mg/kg/dose Frequency: divided every 8-12 hours Note: not to exceed 15 mg/kg/day intramuscular divided every 12 hours at equally divided intervals; continuously high blood levels are desired; daily dose of 15 mg/kg may be given divided every 6-8 hours |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Bacterial infection |
Dose: Intramuscular or intravenous – 15 mg/kg/day Frequency: equally divided doses every 8 to 12 hours Note: Max Dose: 1.5 g/day |
|
Indication: Tuberculosis Age: Children |
Dose: Intramuscular or intravenous – 15–30 mg/kg Frequency: once daily, 5–7 times per week Note: Max Dose: 1 g daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment Creatinine Clearance 50-80 mL/min |
Dose: 60-90% of usual dose Note: Or give every 8-12 hours |
|
Condition: Renal Impairment Creatinine Clearance 10-50 mL/min |
Dose: 30-70% of usual dose Note: Or give every 12 hours |
Administration
- Can be given IM, IV or by infusion
- For IV, dilute in 100-200 mL of fluid
Side Effect
- Agranulocytosis
- Anorexia
- Diarrhea
- Dyspnea
- Edema
- Elevated BUN
- Enterocolitis
- Headache
- Incr salivation
- Muscle cramps
- Muscle weakness
- Nausea
- Nephrotoxicity
- Neurotoxicity
- Ototoxicity
- Pruritus
- Pseudotumor cerebri
- Rash
- Tinnitus
- Thrombocytopenia
- Tremor
- Vertigo
- Weakness
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.